|

Erector Spinae Plane Block Versus Thoracic Epidural Analgesia for Open Liver Resection

RECRUITINGN/ASponsored by Nguyen Toan Thang
Actively Recruiting
PhaseN/A
SponsorNguyen Toan Thang
Started2026-06-15
Est. completion2026-08-15
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted

Summary

Background: Open liver resection is associated with severe postoperative pain. While thoracic epidural analgesia (TEA) is considered the gold standard for pain control, its clinical application is often limited by postoperative coagulation profile derangement, which increases the risk of epidural hematoma. Continuous erector spinae plane block (ESPB) has emerged as a promising, safer alternative with a lower risk of bleeding complications. Objective: This study aims to compare the postoperative analgesic efficacy, safety profiles, and impacts on respiratory function between ultrasound-guided continuous ESPB and TEA in patients undergoing elective open liver resection. Hypothesis: The investigators hypothesize that continuous ESPB using a programmed intermittent bolus (PIB) regimen is non-inferior to TEA regarding 72-hour postoperative pain scores at rest, while offering superior hemodynamic stability and fewer technique-related risks.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* \* Patients aged between 18 and 80 years old.

  * American Society of Anesthesiologists (ASA) physical status classification I to III.
  * Scheduled to undergo elective open liver resection (open hepatectomy).
  * Patient provides written informed consent to participate in the study.

Exclusion Criteria:

* Severe coagulation profile derangement prior to surgery (defined as International Normalized Ratio \[INR\] \> 1.5 or 2.0, or Platelet count \[PLT\] \< 50 G/L or 100 G/L).

  * Severe hepatic impairment (Child-Pugh Class C).
  * Severe chronic obstructive pulmonary disease (COPD GOLD stage III-IV).
  * Severe cardiac dysfunction with an ejection fraction (EF) \< 35%.
  * Severe obesity with a Body Mass Index (BMI) \> 40 kg/m².
  * Localized infection at the planned puncture/needle insertion site.
  * Known allergy or hypersensitivity to local anesthetics (e.g., Ropivacaine) or opioids (e.g., Morphine).
  * Pregnancy or current lactation.

Conditions5

CancerHepatic ResectionLiver CancerLiver DiseaseLiver Neoplasms

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.